Numerous molecular mechanisms, including the loss of tumor suppressors PTEN, p53, or BRCA1, as well as the overactivation of the PI3K/Akt/mTOR or MAPK pathways, regulate the abnormal activation of HIF-1α and HIF-2α in breast cancer. Here, AKT1 is linked to breast cancer.